Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1669.90-9.85 (-0.59 %)
PREV CLOSE () 1679.75
OPEN PRICE () 1673.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2298
TODAY'S LOW / HIGH ()1655.45 1687.35
52 WK LOW / HIGH ()1200 2130
NSE1669.80-8.8 (-0.52 %)
PREV CLOSE() 1678.60
OPEN PRICE () 1678.90
BID PRICE (QTY) 1669.80 (25)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25757
TODAY'S LOW / HIGH() 1656.90 1680.00
52 WK LOW / HIGH ()1277.8 2131
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Srinivas Sadu - Chairman - Managing Director

Registered Office :

Address : Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone : 040 30510999

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
04Nov Gland Pharma reports 12% rise in Q2 co
Gland Pharma has reported result for second quarter ended September 30,..
03Nov Gland Pharma informs about outcome of
In continuation to intimation dated October 17, 2025, regarding the Boar..
17Oct Gland Pharma informs about analyst meet
Gland Pharma has informed that the Earnings Call for Investors/Analysts..
17Oct Gland Pharma informs about earnings c
Gland Pharma has informed that the Earnings Call for Investors/Analysts..
08Sep Gland Pharma informs about investor me
Pursuant to Regulation 30 read with Part A of the Securities and Exchang..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit3019.9510897.53
Gross Profit 4086.73 14655.85
Operating Profit 4574.7916576.93
Net Sales 10741.5241161.49
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 16500.00 (2.63%)
M.Cap ( in Cr)
21169.32
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Procter&Gamble Healt (BSE)
 5663.25 (1.51%)
M.Cap ( in Cr)
9400.65
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2375.00 (2.90%)
M.Cap ( in Cr)
3928.02
Shareholding Pattern
PROMOTERS 51.83%
MUTUAL FUNDS/UTI 30.19%
NON-INSTITUTION 7.63%
FI/BANKS/INSURANCE 1.3%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI